PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
- Status
- SUSPENDED
- Phase
- PHASE1
Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Status
- RECRUITING
- Phase
- PHASE3
Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Pembrolizumab Plus Olaparib in LA-HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
- Status
- RECRUITING
- Phase
- PHASE3
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- NA
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
- Status
- RECRUITING
- Phase
- PHASE3
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)
- Status
- RECRUITING
- Phase
- PHASE2
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
- Status
- RECRUITING
- Phase
- PHASE1
Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)
- Status
- RECRUITING
- Phase
- PHASE2